Rothschild & CO Asset Management Us Inc. Fibrogen Inc Transaction History

Rothschild & CO Asset Management Us Inc.

$6.56 Billion
Q4 2022

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 09, 2021	SELL	$10.18 - $26.64 $1.92 Million - $5.03 Million	-188,818 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$18.57 - $35.68 $4.18 Million - $8.02 Million	-224,838 Reduced 54.35%	188,818 $5.03 Million
Q1 2021 May 14, 2021	SELL	$31.0 - $55.72 $3.63 Million - $6.52 Million	-117,098 Reduced 22.06%	413,656 $14.4 Million
Q4 2020 Feb 08, 2021	SELL	$37.09 - $48.97 $2.59 Million - $3.42 Million	-69,793 Reduced 11.62%	530,754 $19.7 Million
Q3 2020 Nov 09, 2020	SELL	$40.47 - $45.5 $2.65 Million - $2.98 Million	-65,572 Reduced 9.84%	600,547 $24.7 Million
Q2 2020 Aug 10, 2020	BUY	$32.57 - $42.83 $17.4 Million - $22.9 Million	534,092 Added 404.53%	666,119 $27 Million
Q1 2020 May 14, 2020	SELL	$23.3 - $45.96 $668,127 - $1.32 Million	-28,675 Reduced 17.84%	132,027 $4.59 Million
Q4 2019 Feb 12, 2020	BUY	$34.58 - $48.06 $547,574 - $761,030	15,835 Added 10.93%	160,702 $6.89 Million
Q3 2019 Nov 08, 2019	SELL	$36.98 - $48.45 $63,383 - $83,043	-1,714 Reduced 1.17%	144,867 $5.36 Million
Q2 2019 Jul 25, 2019	BUY	$35.13 - $55.53 $309,038 - $488,497	8,797 Added 6.38%	146,581 $6.62 Million
Q1 2019 May 08, 2019	SELL	$42.83 - $59.91 $707,637 - $989,833	-16,522 Reduced 10.71%	137,784 $7.49 Million
Q4 2018 Feb 05, 2019	BUY	$37.97 - $60.16 $330,794 - $524,113	8,712 Added 5.98%	154,306 $7.14 Million
Q3 2018 Nov 13, 2018	SELL	$56.3 - $67.25 $205,213 - $245,126	-3,645 Reduced 2.44%	145,594 $8.85 Million
Q2 2018 Aug 07, 2018	BUY	$44.9 - $64.95 $60,570 - $87,617	1,349 Added 0.91%	149,239 $9.34 Million
Q1 2018 May 08, 2018	SELL	$45.35 - $61.65 $270,558 - $367,803	-5,966 Reduced 3.88%	147,890 $6.83 Million
Q4 2017 Feb 12, 2018	SELL	$41.95 - $60.1 $815,424 - $1.17 Million	-19,438 Reduced 11.22%	153,856 $7.29 Million
Q3 2017 Nov 08, 2017	BUY	$33.4 - $53.9 $5.79 Million - $9.34 Million	173,294	173,294 $9.32 Million

Others Institutions Holding FGEN

# of Institutions

115

Shares Held

57.5M

Call Options Held

2.14M

Put Options Held

907K

Primecap Management CO Pasadena, CA

13.7M
Shares

$5.6 Million
0.01% of portfolio
Armistice Capital, LLC New York, NY

8.94M
Shares

$3.66 Million
0.1% of portfolio
Vanguard Group Inc Valley Forge, PA

5.89M
Shares

$2.41 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

3.36M
Shares

$1.38 Million
0.01% of portfolio
Black Rock Inc. New York, NY

2.41M
Shares

$987,956
0.0% of portfolio

View Full List

About FIBROGEN INC

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $38.4M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

More about FGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild & CO Asset Management Us Inc., based on Form 13F filings with the SEC.

News

Stay updated on Rothschild & CO Asset Management Us Inc. with notifications on news.

Account